NCT02423642View on ClinicalTrials.gov

Immunomodulation Effect of Regional Citrate Anticoagulation in Acute Kidney Injury Requiring Continuous Renal Replacement Therapy

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

November 30, 2014

Study Completion Date

November 30, 2014

Conditions
Acute Kidney Injury
Interventions
PROCEDURE

Continuous renal replacement therapy with regional citrate anticoagulation

"CRRT with anticoagulant : regional citrate anticoagulation~Filter : AQUAMAX™ (Edwards Lifesciences)"

PROCEDURE

Continuous renal replacement therapy with no anticoagulation or heparin

CRRT with any anticoagulant : no anticoagulation or heparin Filter : AQUAMAX™ (Edwards Lifesciences)

Trial Locations (1)

10330

Sasipha Tachaboon, Bangkok

All Listed Sponsors
lead

Chulalongkorn University

OTHER

NCT02423642 - Immunomodulation Effect of Regional Citrate Anticoagulation in Acute Kidney Injury Requiring Continuous Renal Replacement Therapy | Biotech Hunter | Biotech Hunter